Drug Delivery Systems Expert in Controlled Release Pharmaceuticals
A drug delivery systems expert was sought for a patent infringement case involving controlled release pharmaceutical technology. A particular pharmaceutical product was only effective when released slowly into the bloodstream and only became viable with the introduction of pharmaceutical technology for controlled release. The patent claimed a drug delivery system using controlled-release materials to deliver a sustained dosage over a period of time.
IMS ExpertServices provided a drug delivery systems expert with knowledge and experience in working with controlled-release materials for pharmaceuticals. The client requested an expert with an advanced degree in pharmacology or pharmaceutical science and a familiarity with the patent process.
Pharmaceutical Development Expert
This pharmaceutical development expert is a professor of pharmaceutical sciences and a research pharmacologist at a large university. He began his career in pharmaceutical research and development at the Upjohn Company where he headed research into drug formulation and drug delivery systems. This expert earned his B.A. degree in chemistry and M.S. and Ph.D. degrees in pharmaceutical chemistry. He is a member of the American Association of Pharmaceutical Scientists (AAPS) and has been published in the Journal of Pharmaceutical Sciences. He has published over 100 research papers and is a patent holder. IMS Reference #5033552
Pharmaceutical Research Expert
This pharmaceutical research expert has extensive experience in creating controlled-release materials. He has worked with a variety of systems for obtaining controlled release and was a pioneer in microencapsulation as a potential in controlled-release applications. He has worked with controlled-release, delayed-action, and repetitive acting drugs loaded via microencapsulation, infusion, tablet, or in transdermal systems. He is currently a professor of and holds a doctorate degree in pharmaceutical sciences. This expert has served as an expert consultant on drug delivery systems for a large number of pharmaceutical companies and for the federal government. IMS Reference #333244